Nautilus Biotechnology, Inc. — SCHEDULE 13D/A Filings
6 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by Nautilus Biotechnology, Inc. (NAUT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Nautilus Biotechnology, Inc. has filed 6 SCHEDULE 13D/A documents with the SEC since 2020. To view all SEC filings by Nautilus Biotechnology, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001378830-26-000005 | Mar 4, 2026 | — |
| SCHEDULE 13D/A | — | 0001857948-26-000003 | Mar 4, 2026 | — |
| SCHEDULE 13D/A | — | 0001104659-25-062136 | Jun 24, 2025 | — |
| SCHEDULE 13D/A | — | 0001808805-25-000033 | Mar 5, 2025 | — |
| SCHEDULE 13D/A | — | 0001808805-25-000032 | Mar 5, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-011961 | Jan 31, 2025 | — |